You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (71)

Journals (0)

1-10 of 71 results for anti-PD-L1 antibodies

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Fluorouracil enhances the anti-pancreatic cancer effect of anti-PD-L1 antibodies via up-regulating the expression of PD-L1 in cancer cells

Retricted access

Research article

First published 2025-3

Fluorouracil enhances the anti-pancreatic cancer effect of anti-PD-L1 antibodies via up-regulating the expression of PD-L1 in cancer cells

Wei Wang, Sujing Zhang, Cong Wang [...]

Journal of Investigative Medicine

Select article: 89 Zr-Labeled Anti-PD-L1 Antibody Fragment for Evaluating In Vivo PD-L1 Levels in Melanoma Mouse Model

Retricted access

Research article

First published 2020-10

89 Zr-Labeled Anti-PD-L1 Antibody Fragment for Evaluating In Vivo PD-L1 Levels in Melanoma Mouse Model

Caleb Bridgwater, Anne Geller, Xiaoling Hu [...]

Cancer Biotherapy and Radiopharmaceuticals

Select article: Immuno-PET Imaging of the Programmed Cell Death-1 Ligand (PD-L1) Using a Zirconium-89 Labeled Therapeutic Antibody,Avelumab

Open access

Research article

First published 2019

Immuno-PET Imaging of the Programmed Cell Death-1 Ligand (PD-L1) Using a Zirconium-89 Labeled Therapeutic Antibody,Avelumab

Elaine M. Jagoda, Olga Vasalatiy, Falguni Basuli [...]

Molecular Imaging

Select article: Anti-Tumor Efficacy of Anti-PD-1/PD-L1 Antibodies in Combination With Other Anticancer Drugs in Solid Tumors: A Systematic Review and Meta-Analysis

Open access

Research article

First published 2022-11

Anti-Tumor Efficacy of Anti-PD-1/PD-L1 Antibodies in Combination With Other Anticancer Drugs in Solid Tumors: A Systematic Review and Meta-Analysis

Takashi Inoue, Mamoru Narukawa

Cancer Control

Select article: Novel Treatment of Melanoma: Combined Parasite-Derived Peptide GK-1 and Anti-Programmed Death Ligand 1 Therapy

Retricted access

Research article

First published 2017-03

Novel Treatment of Melanoma: Combined Parasite-Derived Peptide GK-1 and Anti-Programmed Death Ligand 1 Therapy

Jesus Vera-Aguilera, Armando Perez-Torres, Diego Beltran [...]

Cancer Biotherapy and Radiopharmaceuticals

Select article: Removal of N-Linked Glycosylation Enhances PD-L1 Detection in Colon Cancer: Validation Research Based on Immunohistochemistry Analysis

Open access

Research article

First published 2021

Removal of N-Linked Glycosylation Enhances PD-L1 Detection in Colon Cancer: Validation Research Based on Immunohistochemistry Analysis

Junying Xu, Xuejing Yang, Yong Mao [...]

Technology in Cancer Research & Treatment

Select article: Pembrolizumab in the treatment of metastatic non-small cell lung cancer: a review of current evidence

Free access

Review article

First published 2017-9

Pembrolizumab in the treatment of metastatic non-small cell lung cancer: a review of current evidence

Karim Rihawi, Francesco Gelsomino, Francesca Sperandi [...]

Therapeutic Advances in Respiratory Disease

Select article: Brain-derived programmed death-ligand 1 mediates immunosuppression post intracerebral hemorrhage

Free access

Research article

First published 2022-11

Brain-derived programmed death-ligand 1 mediates immunosuppression post intracerebral hemorrhage

Nuo Cheng, Hong Wang, Ming Zou [...]

Journal of Cerebral Blood Flow & Metabolism

Select article: Current Clinical Progress of PD-1/PD-L1 Immunotherapy and Potential Combination Treatment in Non–Small Cell Lung Cancer

Open access

Review article

First published 2019

Current Clinical Progress of PD-1/PD-L1 Immunotherapy and Potential Combination Treatment in Non–Small Cell Lung Cancer

Jia-Xin Li, Ju-Min Huang, Ze-Bo Jiang [...]

Integrative Cancer Therapies

Select article: Pembrolizumab and its role in relapsed/refractory classical Hodgkin’s lymphoma: evidence to date and clinical utility

Free access

Review article

First published 2018-4

Pembrolizumab and its role in relapsed/refractory classical Hodgkin’s lymphoma: evidence to date and clinical utility

Polina Shindiapina, Lapo Alinari

Therapeutic Advances in Hematology

1
2
3
•••
8
10 / page

Article type

Publication date

Subjects

Access